Thermo Fisher Q2 profit jumps 58% on life sciences growth By Reuters

© Reuters.

(Reuters) – Thermo Fisher Scientific Inc (NYSE:) posted a 58.2% jump in quarterly profit on Wednesday, boosted by strength in its life sciences unit which makes raw materials for COVID-19 vaccines as well as robust sales of its analytical instruments.

The company’s net income rose to $1.83 billion, or $4.61 per share, for the second quarter ended July 3, from $1.16 billion, or $2.90 per share, a year earlier.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2019 Billionaire Club Co LLC. All rights reserved

Loading the chat ...